Project Ex Vivo
Project Ex Vivo is a groundbreaking collaboration between Microsoft Research and the Broad Institute. We harness the power of AI and machine learning to guide our cancer research. This initiative aims to define, engineer, and target cell states in cancer, driving innovative advancements in precision oncology.